Pancreatic lipase inhibitors, which can make pancreatic lipase lose part of the decomposition ability and thereby reduce the accumulation of fatty acids in the body, are considered as one class of effective anti-obesity agents [3]. This evidence concerns the gene PNLIP and obesity disorder.